Background Artemisinin-based combinations are recommended for treatment of
uncomplicated falciparum malaria, but are costly and in limited supply. Clindamycin plus …

Background Artemisinin-combination therapy (ACT) is recommended as first-line treatment
of falciparum malaria throughout the world, and fixed-dose combinations are preferred by …

Background The WHO recommends artemisinin-based combination therapies (ACTs) for the
treatment of uncomplicated falciparum malaria. Hence, monitoring the efficacy of …

Background Artemether‐lumefantrine is being recommended by the World Health
Organization for treating uncomplicated malaria. It is expensive. We sought evidence of its …

Abstract Background The World Health Organization (WHO) recommends Artemisinin‐
based Combination Therapy (ACT) for treating uncomplicated Plasmodium falciparum …

Background Using a pilot system we have categorised this review as: Current question‐no
update intended (topic covered in another review. Refer to: Sinclair D, Zani B, Donegan S …

Background Artemisinin derivatives may have advantages over quinoline drugs for treating
severe malaria since they are fast acting and effective against quinine resistant malaria …

Background Malaria is a major public health problem in endemic countries including Sudan,
where about 75% of populations are at risk. Due to widespread of chloroquine-resistant …

Background The choice of appropriate artemisinin-based combination therapy depends on
several factors (cost, efficacy, safety, reinfection rate and simplicity of administration). To …

Background Artemisinin-based combination therapy (ACT) was deployed in 2005 as an
alternative to chloroquine and is considered the most efficacious treatment currently …